Back
Pacific Biosciences of California Vs. Axogen Industry Stock Comparison
Sell
40
PACB
Pacific Biosciences of California
Last Price:
1.69
Seasonality Move:
-2.25%
Sell
27
AXGN
Axogen
Last Price:
6.55
Seasonality Move:
18.96%
Sell
40
Pacific Biosciences of California (PACB)
is a Sell
Is Pacific Biosciences of California a Buy, Sell or Hold?
- The current Pacific Biosciences of California [PACB] share price is $1.69. The Score for PACB is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- PACB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Axogen (AXGN)
is a Sell
Is Axogen a Buy, Sell or Hold?
- The current Axogen [AXGN] share price is $6.56. The Score for AXGN is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- AXGN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PACB Stock Price Chart
What is Pacific Biosciences of California's stock price today?
-
The Pacific Biosciences of California share price today is $1.69
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PACB is experiencing slight selling pressure.
AXGN Stock Price Chart
PACB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.63 | Sell |
Relative Strength Index (14 RSI): | 30.1 | Sell |
Chaikin Money Flow: | -1876860 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.52 - 3.46) | Sell |
Bollinger Bands (100): | (3.06 - 8.2) | Sell |
AXGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.41 | Sell |
Relative Strength Index (14 RSI): | 35.97 | Sell |
Chaikin Money Flow: | -29343 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.66 - 7.8) | Sell |
Bollinger Bands (100): | (7.01 - 9.53) | Sell |
PACB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.52 | Buy |
20-day SMA: | 2.22 | Sell |
50-day SMA: | 3.47 | Sell |
200-day SMA: | 7.57 | Sell |
8-day EMA: | 1.64 | Buy |
20-day EMA: | 2.14 | Sell |
50-day EMA: | 3.4 | Sell |
200-day EMA: | 6.71 | Sell |
AXGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.69 | Sell |
20-day SMA: | 7.05 | Sell |
50-day SMA: | 8.08 | Sell |
200-day SMA: | 7.06 | Sell |
8-day EMA: | 6.66 | Sell |
20-day EMA: | 7.01 | Sell |
50-day EMA: | 7.64 | Sell |
200-day EMA: | 7.77 | Sell |
Pacific Biosciences of California Earnings Growth & PACB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.01 per share, an increase this year of $0.16 per share, and an increase next year of $0.19 per share.
Axogen Earnings Growth & AXGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.04 per share, an increase this year of $0.09 per share, and an increase next year of $0.32 per share.
Pacific Biosciences of California Technical Analysis
Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Axogen Technical Analysis
Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |